| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| P R Flatt, C J Bailey, P Kwasowski, T Page, V Mark. Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice. The Journal of endocrinology. vol 101. issue 3. 1984-07-17. PMID:6374002. |
fasting suppressed and refeeding promptly restored plasma gip and insulin concentrations. |
1984-07-17 |
2023-08-12 |
mouse |
| P R Flatt, C J Bailey, P Kwasowski, T Page, V Mark. Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice. The Journal of endocrinology. vol 101. issue 3. 1984-07-17. PMID:6374002. |
administration of gip to mimic postprandial concentrations evoked a marked but transient insulin response which was protracted in the presence of rising hyperglycaemia. |
1984-07-17 |
2023-08-12 |
mouse |
| P R Flatt, C J Bailey, P Kwasowski, T Page, V Mark. Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice. The Journal of endocrinology. vol 101. issue 3. 1984-07-17. PMID:6374002. |
consistent with glucose-potentiation, a mixture of all three nutrients greatly augmented the insulin response without further increase of plasma gip. |
1984-07-17 |
2023-08-12 |
mouse |
| P R Flatt, C J Bailey, P Kwasowski, T Page, V Mark. Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice. The Journal of endocrinology. vol 101. issue 3. 1984-07-17. PMID:6374002. |
glucose-induced increase in endogenous insulin and doses of exogenous insulin up to 100 units/kg did not suppress basal, fat-stimulated or glucose-stimulated gip release. |
1984-07-17 |
2023-08-12 |
mouse |
| U R Fölsch, A Schafmayer, R Ebert, H D Becker, W Creutzfeld. Elevated plasma cholecystokinin concentrations in exocrine pancreatic atrophy in the rat. Digestion. vol 29. issue 1. 1984-07-09. PMID:6373466. |
plasma concentrations of gastrin were significantly decreased by 44% and of gastric inhibitory polypeptide (gip) significantly increased by 24%, while the decrease of the plasma insulin did not reach the level of significance. |
1984-07-09 |
2023-08-12 |
rat |
| B Hagander, B Scherstén, N G Asp, G Sartor, C D Agardh, J Schrezenmeir, H Kasper, B Ahrén, I Lundquis. Effect of dietary fibre on blood glucose, plasma immunoreactive insulin, C-peptide and GIP responses in non insulin dependent (type 2) diabetics and controls. Acta medica Scandinavica. vol 215. issue 3. 1984-07-02. PMID:6328896. |
effect of dietary fibre on blood glucose, plasma immunoreactive insulin, c-peptide and gip responses in non insulin dependent (type 2) diabetics and controls. |
1984-07-02 |
2023-08-12 |
Not clear |
| M El-Salhy, S Falkmer, K J Kramer, R D Speir. Immunocytochemical evidence for the occurrence of insulin in the frontal ganglion of a Lepidopteran insect, the tobacco hornworm moth, Manduca sexta L. General and comparative endocrinology. vol 54. issue 1. 1984-07-02. PMID:6373493. |
immunocytochemical evidence for the occurrence of insulin in the frontal ganglion of a lepidopteran insect, the tobacco hornworm moth, manduca sexta l. the frontal ganglion of the adult forms of the tobacco hornworm, manduca sexta, was investigated immunocytochemically for the occurrence of the gastro-entero-pancreatic (gep) neurohormonal peptides, namely insulin, nerve growth factor, epidermal growth factor, insulin c-peptide, somatostatin, glucagon, glicentin, pancreatic polypeptide (pp), polypeptide yy (pyy), secretin, vasoactive intestinal peptide (vip), gastric inhibitory peptide (gip), gastrin, cholecystokinin (cck), enkephalin, alpha- and beta-endorphins, substance p, neurotensin, bombesin, motilin, acth, serotonin, and calcitonin. |
1984-07-02 |
2023-08-12 |
Not clear |
| F J Service, R A Rizza, R E Westland, L D Hall, J E Gerich, V L G. Gastric inhibitory polypeptide in obesity and diabetes mellitus. The Journal of clinical endocrinology and metabolism. vol 58. issue 6. 1984-07-02. PMID:6373812. |
gastric inhibitory polypeptide (gip) concentrations may be influenced by obesity, diabetes, and glucagon deficiency and be under feedback inhibition by insulin. |
1984-07-02 |
2023-08-12 |
human |
| F J Service, R A Rizza, R E Westland, L D Hall, J E Gerich, V L G. Gastric inhibitory polypeptide in obesity and diabetes mellitus. The Journal of clinical endocrinology and metabolism. vol 58. issue 6. 1984-07-02. PMID:6373812. |
insulin infusion by an artificial endocrine pancreas resulted in postprandial insulin and glucose profiles that approximated those of nondiabetics, but did not significantly alter gip responses to the mixed meal (48.2 +/- 5.5 ng ml-1 240 min-1) in the 18 diabetic patients compared to results obtained with sc insulin treatment (42.2 +/- 5.2 ng ml-1 240 min-1). |
1984-07-02 |
2023-08-12 |
human |
| F J Service, R A Rizza, R E Westland, L D Hall, J E Gerich, V L G. Gastric inhibitory polypeptide in obesity and diabetes mellitus. The Journal of clinical endocrinology and metabolism. vol 58. issue 6. 1984-07-02. PMID:6373812. |
in addition, gip does not appear to be under feedback inhibition by insulin or influenced by glucagon deficiency in diabetes. |
1984-07-02 |
2023-08-12 |
human |
| G Schattenmann, R Ebert, R Siewert, W Creutzfeld. Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum. Scandinavian journal of gastroenterology. vol 19. issue 2. 1984-06-20. PMID:6372074. |
gastric inhibitory polypeptide (gip), insulin, and blood glucose after ingestion of glucose or fat were examined in patients after gastrectomy with esophagojejunostomy or esophagoduodenostomy. |
1984-06-20 |
2023-08-12 |
human |
| O Lawaetz, A M Blackburn, S R Bloom, Y Aritas, D N Ralph. Gut hormone profile and gastric emptying in the dumping syndrome. A hypothesis concerning the pathogenesis. Scandinavian journal of gastroenterology. vol 18. issue 1. 1984-05-30. PMID:6372067. |
insulin, enteroglucagon, neurotensin, gastric inhibitory polypeptide (gip), and motilin have been measured in plasma during an oral glucose test in 76 patients before or after different upper gastrointestinal operations for peptic ulceration. |
1984-05-30 |
2023-08-12 |
Not clear |
| O Lawaetz, A M Blackburn, S R Bloom, Y Aritas, D N Ralph. Gut hormone profile and gastric emptying in the dumping syndrome. A hypothesis concerning the pathogenesis. Scandinavian journal of gastroenterology. vol 18. issue 1. 1984-05-30. PMID:6372067. |
insulin, enteroglucagon, neurotensin, and gip rose significantly in all patients. |
1984-05-30 |
2023-08-12 |
Not clear |
| R Jorde, P F Amland, P G Burhol, K E Giercksky, R Eber. GIP and insulin responses to a test meal in healthy and obese subjects. Scandinavian journal of gastroenterology. vol 18. issue 8. 1984-05-18. PMID:6369517. |
gip and insulin responses to a test meal in healthy and obese subjects. |
1984-05-18 |
2023-08-12 |
human |
| D L Sarson, S M Wood, P C Kansal, S R Bloo. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology? Diabetes. vol 33. issue 4. 1984-05-14. PMID:6368294. |
glucose-dependent insulinotropic polypeptide (gip) is said to be a major physiologic factor in the augmentation of the insulin response to oral glucose. |
1984-05-14 |
2023-08-12 |
human |
| D L Sarson, S M Wood, P C Kansal, S R Bloo. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology? Diabetes. vol 33. issue 4. 1984-05-14. PMID:6368294. |
whether gip promotes insulin release at physiologic concentrations of glucose or gip, however, is questionable. |
1984-05-14 |
2023-08-12 |
human |
| D L Sarson, S M Wood, P C Kansal, S R Bloo. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology? Diabetes. vol 33. issue 4. 1984-05-14. PMID:6368294. |
no significant enhancement of glucose-stimulated insulin secretion was seen when gip was infused with 10 or 20 g i.v. |
1984-05-14 |
2023-08-12 |
human |
| D L Sarson, S M Wood, P C Kansal, S R Bloo. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology? Diabetes. vol 33. issue 4. 1984-05-14. PMID:6368294. |
the higher dose of gip caused a further increase in insulin response (30-min increment, 972 +/- 191 pmol/l; compared with glucose alone, 356 +/- 100 pmol/l, p less than 0.01; and compared with low gip, 602 +/- 247 pmol/l, p less than 0.02). |
1984-05-14 |
2023-08-12 |
human |
| D L Sarson, S M Wood, P C Kansal, S R Bloo. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology? Diabetes. vol 33. issue 4. 1984-05-14. PMID:6368294. |
the concentration of gip and glucose required to produce significant potentiation of the insulin response appears to be in the pharmacologic, rather than physiologic, range. |
1984-05-14 |
2023-08-12 |
human |
| G Collier, A McLean, K O'De. Effect of co-ingestion of fat on the metabolic responses to slowly and rapidly absorbed carbohydrates. Diabetologia. vol 26. issue 1. 1984-05-07. PMID:6368300. |
this was sufficient to raise the glucose levels above the threshold reported for gip to potentiate insulin secretion. |
1984-05-07 |
2023-08-12 |
Not clear |